FR2738567B1 - Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique - Google Patents

Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique

Info

Publication number
FR2738567B1
FR2738567B1 FR9510511A FR9510511A FR2738567B1 FR 2738567 B1 FR2738567 B1 FR 2738567B1 FR 9510511 A FR9510511 A FR 9510511A FR 9510511 A FR9510511 A FR 9510511A FR 2738567 B1 FR2738567 B1 FR 2738567B1
Authority
FR
France
Prior art keywords
phenylpiperidine
alpha
preparation
therapeutic application
propanol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9510511A
Other languages
English (en)
French (fr)
Other versions
FR2738567A1 (fr
Inventor
Jonathan Frost
Bernard Gaudilliere
Jean Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9510511A priority Critical patent/FR2738567B1/fr
Priority to AU69343/96A priority patent/AU6934396A/en
Priority to PCT/FR1996/001361 priority patent/WO1997009310A1/fr
Priority to ZA967558A priority patent/ZA967558B/xx
Priority to ARP960104269A priority patent/AR003529A1/es
Publication of FR2738567A1 publication Critical patent/FR2738567A1/fr
Application granted granted Critical
Publication of FR2738567B1 publication Critical patent/FR2738567B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9510511A 1995-09-08 1995-09-08 Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique Expired - Lifetime FR2738567B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9510511A FR2738567B1 (fr) 1995-09-08 1995-09-08 Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
AU69343/96A AU6934396A (en) 1995-09-08 1996-09-05 1-phenyl-3-4-{benzylpiperidinyl-1}-propanol-1 derivatives, preparation thereof and therapeutical application thereof
PCT/FR1996/001361 WO1997009310A1 (fr) 1995-09-08 1996-09-05 Derives de 1-phenyl-3-[4-benzylpiperidinyl-1]-propanol-1, leur preparation et leur application en therapeutique
ZA967558A ZA967558B (en) 1995-09-08 1996-09-06 Alpha-phenylpiperidine-1-propanol derivatives their preparation and their application in therapeutics
ARP960104269A AR003529A1 (es) 1995-09-08 1996-09-06 Derivados de alfa-fenilpiperidin-1-propanol, procedimiento para su preparacion y su aplicacion terapeutica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510511A FR2738567B1 (fr) 1995-09-08 1995-09-08 Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2738567A1 FR2738567A1 (fr) 1997-03-14
FR2738567B1 true FR2738567B1 (fr) 1997-10-17

Family

ID=9482363

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9510511A Expired - Lifetime FR2738567B1 (fr) 1995-09-08 1995-09-08 Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique

Country Status (5)

Country Link
AR (1) AR003529A1 (xx)
AU (1) AU6934396A (xx)
FR (1) FR2738567B1 (xx)
WO (1) WO1997009310A1 (xx)
ZA (1) ZA967558B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511868A (ja) 1997-06-30 2002-04-16 アラーガン・セイルズ・インコーポレイテッド 増殖性硝子体網膜症を治療するためのカルシウム遮断薬
KR20020002356A (ko) 1998-10-27 2002-01-09 제임스 에이. 아노 외부 망막 손상의 치료

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2620704B1 (fr) * 1987-09-17 1991-04-26 Sanofi Sa Derives de (benzyl-4 piperidino)-1 propanol-2, leur preparation, leur utilisation comme antimicrobiens et les produits les contenant
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
AR003529A1 (es) 1998-08-05
FR2738567A1 (fr) 1997-03-14
WO1997009310A1 (fr) 1997-03-13
AU6934396A (en) 1997-03-27
ZA967558B (en) 1997-03-25

Similar Documents

Publication Publication Date Title
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
MA22981A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique.
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2675799B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2728570B1 (fr) Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2638747B1 (fr) Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2738567B1 (fr) Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2674853B1 (fr) Derives de piperidinylguanidine, leur preparation et leur application en therapeutique.
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2724383B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2754261B1 (fr) Derives de quinuclidine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name